3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Neoplasm Metastasis
8
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Meningeal Carcinomatosis
1
HER2-mutant Non-Small Cell Lung Cancer
1
Gastrointestinal Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Cisplatin
7
Cetuximab
6
Radiotherapy, Intensity-Modulated
4
pembrolizumab
3
durvalumab
3
Radiotherapy
2
Radiation
2
Observation
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
trametinib
1
sodium thiosulfate
1
gluconic acid
1
ficlatuzumab
1
Zinc
1
Watchful Waiting
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Tadalafil
1
Sirolimus
1
RRx-001
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Photochemotherapy
1
Periodontal Debridement
1
Oral Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mouth Neoplasms
×
trastuzumab deruxtecan
×
Clear all
No trials found.